Design of a trial comparing sirolimus plus mycophenolate mofetil versus sirolimus plus cyclosporine

Claudio Ponticelli, A. Tarantino, A. Aroldi, V. Sparacino, S. Stefoni, F. Citterio, L. Duca, M. P. Scolari, S. Calabrese, P. Altieri, G. Civati, B. Cesana

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

We present the study design of a prospective, multicenter, randomized trial aimed at comparing the effects of two different combinations of sirolimus. Renal transplant recipients will be allocated to receive either sirolimus and mycophenolate mofetil (group A) or sirolimus and cyclosporine (group B). The primary endpoint will be the graft function at 3, 6, 12, 24, 36, 48, and 60 months. A number of secondary endpoints will also be considered. To obtain a significant difference in the primary endpoint 180 patients will be enrolled.

Original languageEnglish
JournalTransplantation Proceedings
Volume35
Issue number3 SUPPL.
DOIs
Publication statusPublished - May 2003

Fingerprint

Mycophenolic Acid
Sirolimus
Cyclosporine
Multicenter Studies
Transplants
Kidney

ASJC Scopus subject areas

  • Surgery
  • Transplantation

Cite this

Ponticelli, C., Tarantino, A., Aroldi, A., Sparacino, V., Stefoni, S., Citterio, F., ... Cesana, B. (2003). Design of a trial comparing sirolimus plus mycophenolate mofetil versus sirolimus plus cyclosporine. Transplantation Proceedings, 35(3 SUPPL.). https://doi.org/10.1016/S0041-1345(03)00212-4

Design of a trial comparing sirolimus plus mycophenolate mofetil versus sirolimus plus cyclosporine. / Ponticelli, Claudio; Tarantino, A.; Aroldi, A.; Sparacino, V.; Stefoni, S.; Citterio, F.; Duca, L.; Scolari, M. P.; Calabrese, S.; Altieri, P.; Civati, G.; Cesana, B.

In: Transplantation Proceedings, Vol. 35, No. 3 SUPPL., 05.2003.

Research output: Contribution to journalArticle

Ponticelli, C, Tarantino, A, Aroldi, A, Sparacino, V, Stefoni, S, Citterio, F, Duca, L, Scolari, MP, Calabrese, S, Altieri, P, Civati, G & Cesana, B 2003, 'Design of a trial comparing sirolimus plus mycophenolate mofetil versus sirolimus plus cyclosporine', Transplantation Proceedings, vol. 35, no. 3 SUPPL.. https://doi.org/10.1016/S0041-1345(03)00212-4
Ponticelli, Claudio ; Tarantino, A. ; Aroldi, A. ; Sparacino, V. ; Stefoni, S. ; Citterio, F. ; Duca, L. ; Scolari, M. P. ; Calabrese, S. ; Altieri, P. ; Civati, G. ; Cesana, B. / Design of a trial comparing sirolimus plus mycophenolate mofetil versus sirolimus plus cyclosporine. In: Transplantation Proceedings. 2003 ; Vol. 35, No. 3 SUPPL.
@article{d8bb62908bae42afb9e1882585bc6cec,
title = "Design of a trial comparing sirolimus plus mycophenolate mofetil versus sirolimus plus cyclosporine",
abstract = "We present the study design of a prospective, multicenter, randomized trial aimed at comparing the effects of two different combinations of sirolimus. Renal transplant recipients will be allocated to receive either sirolimus and mycophenolate mofetil (group A) or sirolimus and cyclosporine (group B). The primary endpoint will be the graft function at 3, 6, 12, 24, 36, 48, and 60 months. A number of secondary endpoints will also be considered. To obtain a significant difference in the primary endpoint 180 patients will be enrolled.",
author = "Claudio Ponticelli and A. Tarantino and A. Aroldi and V. Sparacino and S. Stefoni and F. Citterio and L. Duca and Scolari, {M. P.} and S. Calabrese and P. Altieri and G. Civati and B. Cesana",
year = "2003",
month = "5",
doi = "10.1016/S0041-1345(03)00212-4",
language = "English",
volume = "35",
journal = "Transplantation Proceedings",
issn = "0041-1345",
publisher = "Elsevier USA",
number = "3 SUPPL.",

}

TY - JOUR

T1 - Design of a trial comparing sirolimus plus mycophenolate mofetil versus sirolimus plus cyclosporine

AU - Ponticelli, Claudio

AU - Tarantino, A.

AU - Aroldi, A.

AU - Sparacino, V.

AU - Stefoni, S.

AU - Citterio, F.

AU - Duca, L.

AU - Scolari, M. P.

AU - Calabrese, S.

AU - Altieri, P.

AU - Civati, G.

AU - Cesana, B.

PY - 2003/5

Y1 - 2003/5

N2 - We present the study design of a prospective, multicenter, randomized trial aimed at comparing the effects of two different combinations of sirolimus. Renal transplant recipients will be allocated to receive either sirolimus and mycophenolate mofetil (group A) or sirolimus and cyclosporine (group B). The primary endpoint will be the graft function at 3, 6, 12, 24, 36, 48, and 60 months. A number of secondary endpoints will also be considered. To obtain a significant difference in the primary endpoint 180 patients will be enrolled.

AB - We present the study design of a prospective, multicenter, randomized trial aimed at comparing the effects of two different combinations of sirolimus. Renal transplant recipients will be allocated to receive either sirolimus and mycophenolate mofetil (group A) or sirolimus and cyclosporine (group B). The primary endpoint will be the graft function at 3, 6, 12, 24, 36, 48, and 60 months. A number of secondary endpoints will also be considered. To obtain a significant difference in the primary endpoint 180 patients will be enrolled.

UR - http://www.scopus.com/inward/record.url?scp=10744224309&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=10744224309&partnerID=8YFLogxK

U2 - 10.1016/S0041-1345(03)00212-4

DO - 10.1016/S0041-1345(03)00212-4

M3 - Article

C2 - 12742469

AN - SCOPUS:10744224309

VL - 35

JO - Transplantation Proceedings

JF - Transplantation Proceedings

SN - 0041-1345

IS - 3 SUPPL.

ER -